Allergy Archives - Ora Clinical

Articles January, 2017 San Diego, CA & Andover, MA - January 5, 2017

Okogen, Inc. to present at 2017 Biotech Showcase

Articles December, 2016 Matthew Chapin, Andrew Warner, Esq., Sena Biswas, PhD

Ophthalmic Product Development Insights

Articles December, 2016 Mark B. Abelson, MD, CM, FRCSC, FARVO, Connie Slocum, PhD, David A. Hollander, MD, MBA

How this particular type of gene editing works and a discussion of its potential uses in the future.

Articles December, 2016 PITTSBURGH--(BUSINESS WIRE)

Second Disease Indication Shows Versatility of Paracrine Signaling Solution

Articles October, 2016 Mark B. Abelson, MD, CM, FRCSC, FARVO, David A. Hollander, MD, MBA, Andrew Hertsenberg, PhD

A look at ocular/nasal interactions and how they can affect our
pharmaceutical therapies.

Articles August, 2016 Mark B. Abelson, MD, CM, FRCSC, FARVO, Lisa M Smith, David A. Hollander, MD, MBA, Dale Usner, PhD

The purpose of any scale is to provide a means to measure a trait, a physical change or any parameter not readily amenable to direct quantitation.

Articles August, 2016 Joseph B. Ciolino, MD

Articles August, 2016 Matt Chapin

Ophthalmic Product Development Insights

Articles July, 2016 Mark B Abelson, MD, CM, FRCSC, FARVO, David Hollander, MD, MBA, Ora Staff

A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.

Articles June, 2016 Mark B Abelson, MD, CM, FRCSC, FARVO, Andrea Leonard-Segal, MD, FACR, James McLaughlin, PhD, David Hollander, MD

Putting two drugs together in one formulation can sometimes achieve better results than either agent can by itself.